ProPhase Labs, Inc. Dividends Payable, Amount Per Share
ProPhase Labs, Inc. (PRPH) had Dividends Payable, Amount Per Share of $0.25 per share as of 2019-11-20, per its 10-K filed 2020-03-26.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:DividendsPayableAmountPerShare · last filed 2020-03-26
- 2019-11-20: Dividends Payable, Amount Per Share $0.25.
- 2018-12-24: Dividends Payable, Amount Per Share $0.25.
- 2018-05-07: Dividends Payable, Amount Per Share $1.00.
| Period end | Dividends Payable, Amount Per Share |
|---|---|
| 2019-11-20 | $0.25 10-K · filed 2020-03-26 |
| 2018-12-24 | $0.25 10-K · filed 2020-03-26 |
| 2018-05-07 | $1.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |